The joint statement—published in Thyroid—was put out by American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging and the European Thyroid Association.

Targeted breast ultrasound should be the first-line imaging test in patients with palpable lumps after mastectomy. Mammography can help confirm suspected cases, but did not find any additional cancers.

“For CCTA to enter the mainstream of diagnostic clinical care, it is necessary to decrease observer variability and automate key parts of the interpretive process to manage the subjectivity, time-consuming nature, and variability of reader interpretation,” wrote authors of a new study published in the European Journal of Radiology.

The American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA) have updated their clinical guidelines for adjuvant and salvage radiotherapy following prostatectomy.

Johns Hopkin’s researchers have created a PET-based approach that can direct cancer drugs to precise points in the brains of mice, according to a study published in the May 1 edition of the Journal of Nuclear Medicine. If proven effective in humans, the researchers believe their technique could help patients with difficult brain tumors, such as glioblastomas.

The Society of Interventional Radiology (SIR) and numerous other societies have endorsed prostatic artery embolization (PEA) as a safe and effective method to treat an enlarged prostate in certain patients.

The prospective single-center study, published April 30 in the American Journal of Roentgenology, adds more weight to the growing literature suggesting PSMA-11’s vital role in prostate cancer management.

“The results of this study demonstrate proof of the concept that DL models may aid in the prediction of thrombolysis outcomes,” wrote authors of an April 30 study published in Academic Radiology.

“With imaging, we’ll be able to identify vulnerable plaque, deliver treatment directly to it, and see whether the treatment is effective," said award recipient Yongjian Liu, PhD, with Washington University in St. Louis.

The 2017 Liver Imaging Reporting and Data System (LI-RADS) included an algorithm to assess hepatocellular carcinoma (HCC) treated with local-regional therapy, but the method was never validated. A team of researchers took on the task, publishing their results April 30 in Radiology.